PhiChem Corporation carries a market capitalization of 28.39B, placing it among publicly traded companies globally. Its enterprise value stands at 14.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 28.39B |
| Enterprise Value | 14.08B |
PhiChem Corporation currently has 566.95M shares outstanding.
| Shares Outstanding | 566.95M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
PhiChem Corporation trades at a trailing price-to-earnings ratio of 44.55. The price-to-sales ratio is 5.80, and the price-to-book ratio stands at 4.92.
| PE Ratio | 44.55 |
| PS Ratio | 5.80 |
| PB Ratio | 4.92 |
| P/TBV Ratio | 3.59 |
| P/FCF Ratio | 30.56 |
| P/OCF Ratio | N/A |
On an enterprise value basis, PhiChem Corporation trades at an EV/EBITDA multiple of 31.72 and an EV/FCF ratio of 28.21. The EV/Sales ratio of 5.59 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 31.72 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.59 |
| EV / EBITDA | 31.72 |
| EV / EBIT | 31.72 |
| EV / FCF | 28.21 |
PhiChem Corporation maintains a current ratio of 2.31, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.17, indicating elevated leverage, while an interest coverage ratio of 18.97 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.31 |
| Quick Ratio | 0.95 |
| Debt / Equity | 16.17 |
| Debt / EBITDA | 1.89 |
| Interest Coverage | 18.97 |
PhiChem Corporation posts a return on equity of 11.52 and a return on invested capital of 6.80.
| Return on Equity (ROE) | 11.52 |
| Return on Assets (ROA) | 4.77 |
| Return on Invested Capital (ROIC) | 6.80 |
| Return on Capital Employed (ROCE) | 8.12 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.30 |
Over the trailing twelve months, PhiChem Corporation has paid 31.90M in income taxes, reflecting an effective tax rate of 8.60.
| Income Tax | 31.90M |
| Effective Tax Rate | 8.60 |
PhiChem Corporation's stock has gained approximately 157.81573% over the past 52 weeks. The 50-day moving average sits at 41.60, while the 200-day moving average is 29.46.
| Beta (5Y) | N/A |
| 52-Week Price Change | 157.81573% |
| 50-Day Moving Average | 41.60 |
| 200-Day Moving Average | 29.46 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, PhiChem Corporation generated 2.52B in revenue and converted that into 327.79M in net income, yielding earnings per share of 0.59. EBITDA reached 443.90M, while operating income came in at 443.90M.
| Revenue | 2.52B |
| Gross Profit | 955.54M |
| Operating Income | 443.90M |
| Pretax Income | 370.89M |
| Net Income | 327.79M |
| EBITDA | 443.90M |
| EBIT | 443.90M |
| Earnings Per Share (EPS) | 0.59 |
PhiChem Corporation holds 1.51B in cash and equivalents against 838.91M in total debt, resulting in a net debt position of -527.41M. Total book value stands at 2.97B, with working capital of 2.08B providing operational flexibility.
| Cash & Cash Equivalents | 1.51B |
| Total Debt | 838.91M |
| Net Debt | -527.41M |
| Equity (Book Value) | 2.97B |
| Book Value Per Share | 5.20 |
| Working Capital | 2.08B |
After subtracting -477.79M in capital expenditures, free cash flow totaled -477.79M - equivalent to -0.84 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -477.79M |
| Free Cash Flow | -477.79M |
| FCF Per Share | -0.84 |
PhiChem Corporation operates with a gross margin of 37.95, reflecting its pricing power and cost economics. The operating margin of 17.63 and net profit margin of 13.02 provide insight into operational efficiency.
| Gross Margin | 37.95 |
| Operating Margin | 17.63 |
| Pretax Margin | 14.73 |
| Profit Margin | 13.02 |
| EBITDA Margin | 17.63 |
The company's payout ratio of 11.63 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.07 |
| Dividend Yield | N/A |
| Payout Ratio | 11.63 |
| Shareholder Yield | 0.45 |
| FCF Yield | 3.27 |
PhiChem Corporation's most recent stock split took place on May 15, 2019 with a 5:6 split ratio.
| Last Split Date | 5/15/2019 |
| Split Ratio | 5:6 |
PhiChem Corporation posts an Altman Z-Score of 6.11, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.11 |